HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
53 hedge funds and large institutions have $109M invested in HOOKIPA Pharma in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
58% more capital invested
Capital invested by funds: $69M → $109M (+$40.2M)
8% more funds holding
Funds holding: 49 → 53 (+4)
0.53% more ownership
Funds ownership: 3.34% → 3.87% (+0.53%)
100% less call options, than puts
Call options by funds: $6K | Put options by funds: $1.73M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.7M |
| 2 |
AG
Artal Group
Luxembourg
|
+$3.78M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.46M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.16M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$972K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$682K |
| 2 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$143K |
| 3 |
Squarepoint
New York
|
-$120K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$99.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$93K |
HOOK Hedge Fund Activity: Q4 2020 in Review
53 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2020, worth a combined $109M — up 58% from $69M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HOOK positions and 6 closed out — a net gain of 4 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $18.7M. The largest seller was Zacks Investment Management, exiting entirely with an estimated $682K sold.
- 53 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2020, up from 49 in Q3 2020.
- Funds reported $109M of HOOKIPA Pharma stock for Q4 2020, up 58% quarter-over-quarter.
- 10 funds opened new HOOKIPA Pharma positions in Q4 2020 and 6 closed out, a net change of +4 holders.
- The largest HOOKIPA Pharma buyer in Q4 2020 was Fidelity Investments, an estimated $18.7M added.
- The largest HOOKIPA Pharma seller in Q4 2020 was Zacks Investment Management, an estimated $682K sold.
Based on aggregated 13F filings for Q4 2020.